We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
251
Exelixis
EXEL
$13.9B
$4.83M 0.09%
223,000
-32,000
-13% -$651K
XLRN
252
DELISTED
Acceleron Pharma
XLRN
$4.82M 0.09%
182,000
+31,000
+21% +$817K
XRAY icon
253
Dentsply Sirona
XRAY
$2.59B
$4.8M 0.09%
76,849
+4,821
+7% +$290K
CFG icon
254
Citizens Financial Group
CFG
$30.4B
$4.79M 0.09%
138,643
+99,052
+250% +$3.61M
GIS icon
255
General Mills
GIS
$19.2B
$4.78M 0.09%
80,936
+6,174
+8% +$377K
HPQ icon
256
HP
HPQ
$23.5B
$4.69M 0.09%
262,509
+45,849
+21% +$742K
NFLX icon
257
Netflix
NFLX
$292B
$4.69M 0.09%
317,270
+59,980
+23% +$842K
RARE icon
258
Ultragenyx Pharmaceutical
RARE
$2.65B
$4.68M 0.09%
69,000
-8,000
-10% -$610K
DD
259
DELISTED
Du Pont De Nemours E I
DD
$4.67M 0.09%
58,182
+10,881
+23% +$845K
TFCF
260
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$4.67M 0.09%
146,987
+123,344
+522% +$3.71M
SU icon
261
Suncor Energy
SU
$77.7B
$4.66M 0.09%
152,055
-26,016
-15% -$819K
DVN icon
262
Devon Energy
DVN
$51.9B
$4.63M 0.09%
111,050
+20,354
+22% +$895K
BOXC
263
DELISTED
Brookfield Can Office Properties
BOXC
$4.63M 0.09%
+197,540
New +$4.54M
PNC icon
264
PNC Financial Services
PNC
$100B
$4.58M 0.09%
38,085
+7,290
+24% +$893K
BEN icon
265
Franklin Resources
BEN
$16.9B
$4.47M 0.09%
106,084
+82,666
+353% +$3.43M
XYL icon
266
Xylem
XYL
$28.5B
$4.42M 0.09%
88,072
+66,271
+304% +$3.23M
SYF icon
267
Synchrony
SYF
$23.7B
$4.4M 0.09%
128,388
+89,158
+227% +$3.2M
LOXO
268
DELISTED
Loxo Oncology, Inc
LOXO
$4.33M 0.08%
103,000
+23,000
+29% +$947K
DISCK
269
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$4.29M 0.08%
151,703
+131,834
+664% +$3.61M
AEE icon
270
Ameren
AEE
$31.5B
$4.25M 0.08%
77,871
+4,291
+6% +$230K
PGR icon
271
Progressive
PGR
$124B
$4.25M 0.08%
108,332
+48,049
+80% +$1.83M
PTC icon
272
PTC
PTC
$13.7B
$4.23M 0.08%
80,521
+50,423
+168% +$2.67M
NTRS icon
273
Northern Trust
NTRS
$22.2B
$4.23M 0.08%
48,859
+3,618
+8% +$315K
AEM icon
274
Agnico Eagle Mines
AEM
$72.6B
$4.22M 0.08%
99,674
-29,283
-23% -$1.32M
ONC
275
BeOne Medicines Ltd
ONC
$33.8B
$4.21M 0.08%
+115,000
New +$4.19M
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.